LBA2_PR - melanoma and other skin tumours Ipilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial
| Autor: | Eggermont, A.M.M., Chiarion-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J.D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P.A., Richards, J.M., Lebbé, C., Ferraresi, V., Smylie, M., Weber, J.S., Taitt, C., de Pril, V., de Schaetzen, G., Suciu, S., Testori, A. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi574-vi574 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|